Coverage
-
November 19, 2010
Jurors returned a verdict Friday in favor of Merck & Co. Inc. in one of a handful of bellwether cases alleging the company’s osteoporosis drug Fosamax can cause bone rotting in patients’ jaws, marking the third win for Merck out of four such cases.
2 other articles on this case.
View all »